Metraipolis › archive › dc_8ec0017f9bfa

Innovative gene engineering strategies to address tumor antigen escape in cell therapy — Europe PMC PMID:41194129

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41194129
DOI: 10.1186/s12967-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-11-08T18:58:28.284Z
SHA-256 of the archived text: fcdf041a53a8c10335ff4d30fbbd08f370cd37a6f4fe69af1c8244a24dbbb03f
Stable URL of this page: https://metraipolis.com/documento/dc_8ec0017f9bfa

How to cite

Innovative gene engineering strategies to address tumor antigen escape in cell therapy — Europe PMC PMID:41194129 — Europe PMC (en), https://europepmc.org/article/MED/41194129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ec0017f9bfa (Metraipolis archive dc_8ec0017f9bfa, sha256 fcdf041a53a8c10335ff4d30fbbd08f370cd37a6f4fe69af1c8244a24dbbb03f)

BibTeX

@misc{dc8ec0017f9bfa,
  title = {Innovative gene engineering strategies to address tumor antigen escape in cell therapy — Europe PMC PMID:41194129},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41194129},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ec0017f9bfa; sha256 fcdf041a53a8c10335ff4d30fbbd08f370cd37a6f4fe69af1c8244a24dbbb03f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194129. Agents can read the archived copy with the MCP tool read_document.